YANKCOM Partnership’s GSK GSK Stock Holding History

YANKCOM Partnership’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-324	Closed	-$17K	–	327
2026 Q2	$17K	Hold	324	–	–	0.01%	235
2026 Q1	$17.9K	Sell	324 -267	-45%	-$14.5K	0.01%	236
2025 Q4	$29K	Buy	+591	New	+$27.6K	0.01%	218
2025 Q3	–	Sell	-86	Closed	-$3.3K	–	305
2025 Q2	$3.3K	Hold	86	–	–	﹤0.01%	270
2025 Q1	$3.33K	Hold	86	–	–	﹤0.01%	263
2024 Q4	$2.91K	Buy	+86	New	+$3.1K	﹤0.01%	245

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

YANKCOM Partnership's GSK Position: Q3 2026 in Review

YANKCOM Partnership sold out of GSK (GSK) in Q3 2026, closing a stake of 324 shares — an estimated $17K sold.

YANKCOM Partnership first reported a position in GSK in Q4 2024 and held it in 6 quarters. The position peaked at $29K in Q4 2025. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

YANKCOM Partnership reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
YANKCOM Partnership sold 324 GSK shares in Q3 2026, an estimated $17K.
YANKCOM Partnership first reported a position in GSK in Q4 2024 and held it in 6 quarters.
YANKCOM Partnership's GSK position peaked at $29K in Q4 2025.
654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.